Acarix
0.223
SEK
0 %
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
Less than 1K followers
0%
-8.23%
-11.16%
-26.77%
-50.33%
+1.36%
-62.03%
-72.89%
-96.98%
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.
Read moreMarket cap
250.5M SEK
Turnover
456.79K SEK
Revenue
6.24M
EBIT %
-1,242.79 %
P/E
-
Dividend yield-%
-
Financial calendar
13.2
2025
Annual report '24
15.5
2025
General meeting '25
ShowingAll content types
Nomination Committee for Acarix Annual General Meeting 2025
Redeye: Acarix Q3 2024 - Setting the stage for an exciting 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools